Thyrocare Technologies Limited has informed the Exchange regarding Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer of the company w.e.f. January 05, 2026.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has appointed Mr. Rajdeep Panwar as its Chief Commercial Officer (CCO), categorised as Senior Management Personnel, effective January 5, 2026. The appointment was approved by the Board via a circulation resolution on the same day, following a recommendation from the Nomination and Remuneration Committee. Mr. Panwar brings over 21 years of experience in the healthcare and diagnostics sector, with prior leadership roles at Medanta Labs, Apollo Diagnostics, Dr. Lal PathLabs, Quest Diagnostics India, and Johnson & Johnson's Ortho Clinical Diagnostics. His expertise spans P&L management, laboratory network expansion, digital diagnostics, and large-scale team leadership.
This is a routine senior management appointment aimed at strengthening Thyrocare's commercial and diagnostic operations leadership. The hiring of an experienced industry professional may support business growth and network expansion, though it is unlikely to cause immediate share price movement.